Stocks and Investing
Stocks and Investing
Tue, July 9, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Robert Burns Reiterated (TNGX) at Strong Buy and Held Target at $13 on, Jul 9th, 2024
Robert Burns of HC Wainwright & Co., Reiterated "Tango Therapeutics, Inc." (TNGX) at Strong Buy and Held Target at $13 on, Jul 9th, 2024.
Robert has made no other calls on TNGX in the last 4 months.
There are 3 other peers that have a rating on TNGX. Out of the 3 peers that are also analyzing TNGX, 0 agree with Robert's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Robert
- Charles Zhu of "Guggenheim" Maintained at Strong Buy with Decreased Target to $14 on, Friday, May 24th, 2024
- Peter Lawson of "Barclays" Maintained at Buy with Decreased Target to $13 on, Friday, May 24th, 2024
- Robert Driscoll of "Wedbush" Maintained at Buy with Decreased Target to $11 on, Thursday, May 23rd, 2024
Contributing Sources